117 related articles for article (PubMed ID: 7865819)
21. Acetylcholinesterase noncovalent inhibitors based on a polyamine backbone for potential use against Alzheimer's disease.
Melchiorre C; Andrisano V; Bolognesi ML; Budriesi R; Cavalli A; Cavrini V; Rosini M; Tumiatti V; Recanatini M
J Med Chem; 1998 Oct; 41(22):4186-9. PubMed ID: 9784091
[No Abstract] [Full Text] [Related]
22. [Opioid peptides, regulators of acetylcholinesterase activity].
Muranevich SA; Polosatov MV
Biull Eksp Biol Med; 1989 Oct; 108(10):457-9. PubMed ID: 2597760
[TBL] [Abstract][Full Text] [Related]
23. [Phosphorus atom availability and mechanism enzyme inhibiting effect of organophosphorous inhibitors of cholinesterases of various origin. Results of conformational and correlational analysis].
Rozengart EV; Shestakova NN; Prokator SO; Basova NE
Zh Evol Biokhim Fiziol; 1999; 35(1):36-9. PubMed ID: 10399821
[No Abstract] [Full Text] [Related]
24. [Kinetics of hydrolysis of the phenyl analog of acetylcholine under the action of cholinesterase from horse serum and acetylcholinesterase from bovine erythrocytes].
Brestkin AP; Brik IL; Teplov NE
Biokhimiia; 1968; 33(5):1059-68. PubMed ID: 5703735
[No Abstract] [Full Text] [Related]
25. Effect of malathion on kinetic parameters of acetylcholinesterase (EC 3.1.1.7) in vitro.
Kamal MA
Biochem Mol Biol Int; 1997 Sep; 43(1):89-97. PubMed ID: 9315286
[TBL] [Abstract][Full Text] [Related]
26. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
Eckert S; Eyer P; Mückter H; Worek F
Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
[TBL] [Abstract][Full Text] [Related]
27. [Properties of bovine brain and erythrocyte acetylcholinesterase].
Brestkin AP; Pevzner DL
Biokhimiia; 1971; 36(1):81-7. PubMed ID: 5556042
[No Abstract] [Full Text] [Related]
28. Synthesis and study of thiocarbonate derivatives of choline as potential inhibitors of acetylcholinesterase.
Boyle NA; Talesa V; Giovannini E; Rosi G; Norton SJ
J Med Chem; 1997 Sep; 40(19):3009-13. PubMed ID: 9301662
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of erythrocyte acetylcholinesterase by peroxides.
O'Malley BW; Mengel CE; Meriwether WD; Zirkle LG
Biochemistry; 1966 Jan; 5(1):40-4. PubMed ID: 5938954
[No Abstract] [Full Text] [Related]
30. [The effect of ionic strength and organic solvents on the interaction between cholinesterase and substrates and phosphoorganic inhibitors].
Brestkin AP; Brik IL; Volkova RI; Maĭzel' EB; Rozengart EV
Biokhimiia; 1970; 35(2):382-93. PubMed ID: 5480182
[No Abstract] [Full Text] [Related]
31. [Substrate and inhibitor specificity of brain cholinesterase of various fly species (Diptera: Anthomyiidae, Muscidae). Enzyme type].
Grigor'eva GM; Krasnova TI; Khovanskikh AE; Lezhneva IP
Zh Evol Biokhim Fiziol; 1997; 33(4-5):431-42. PubMed ID: 9542042
[No Abstract] [Full Text] [Related]
32. Substrate activation of butyrylcholinesterase and substrate inhibition of acetylcholinesterase by 3,3-dimethylbutyl-N-n-butylcarbamate and 2-trimethylsilyl-ethyl-N-n-butylcarbamate.
Chiou SY; Wu YG; Lin YF; Lin LY; Lin G
J Biochem Mol Toxicol; 2007; 21(1):24-31. PubMed ID: 17366539
[TBL] [Abstract][Full Text] [Related]
33. [The effect of obidoximchloride on the activity of acetylcholine splitting enzymes in rats].
Schnurr E; Ammon R
Arzneimittelforschung; 1968 Mar; 18(3):289-91. PubMed ID: 5696002
[No Abstract] [Full Text] [Related]
34. alpha,beta-Dehydrophenylalanine choline esters, a new class of reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Grigoryan HA; Hambardzumyan AA; Mkrtchyan MV; Topuzyan VO; Halebyan GP; Asatryan RS
Chem Biol Interact; 2008 Jan; 171(1):108-16. PubMed ID: 17980356
[TBL] [Abstract][Full Text] [Related]
35. Role of phospholipid (cardiolipin) in the modulation of substrate and inhibitor interactions with erythrocyte acetylcholinesterase.
Roufogalis BD; Beauregard G
Mol Pharmacol; 1979 Jul; 16(1):189-95. PubMed ID: 481418
[No Abstract] [Full Text] [Related]
36. Cholinesterase: substrate inhibition and substrate activation.
Reiner E; Simeon-Rudolf V
Pflugers Arch; 2000; 440(5 Suppl):R118-20. PubMed ID: 11005636
[TBL] [Abstract][Full Text] [Related]
37. [Effect of alkyl-substituted beta-oxy derivatives of pyridine on erythrocyte acetylcholinesterase activity].
Zorina OM; Panasenko OM; Gendel' LIa; Smirnov LD
Izv Akad Nauk SSSR Biol; 1983; (4):609-13. PubMed ID: 6619389
[No Abstract] [Full Text] [Related]
38. Inhibition of acetylcholinesterase from human erythrocytes by isocyanates.
Dewair M; Baur X; Fruhmann G
J Occup Med; 1983 Apr; 25(4):279-82. PubMed ID: 6854416
[TBL] [Abstract][Full Text] [Related]
39. Histochemical localization of acetylcholinesterase in blood cells.
Falugi C
Basic Appl Histochem; 1985; 29(2):105-13. PubMed ID: 4026779
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory potency against human acetylcholinesterase and enzymatic hydrolysis of fluorogenic nerve agent mimics by human paraoxonase 1 and squid diisopropyl fluorophosphatase.
Blum MM; Timperley CM; Williams GR; Thiermann H; Worek F
Biochemistry; 2008 May; 47(18):5216-24. PubMed ID: 18396898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
